Neonatal heart rate variability: a contemporary scoping review of analysis methods and clinical applications

S Latremouille, J Lam, W Shalish, G Sant'Anna - BMJ open, 2021 - bmjopen.bmj.com
Background Neonatal heart rate variability (HRV) is widely used as a research tool.
However, HRV calculation methods are highly variable making it difficult for comparisons …

Laser acupuncture for neonatal abstinence syndrome: a randomized controlled trial

W Raith, GM Schmölzer, B Resch, F Reiterer… - …, 2015 - publications.aap.org
BACKGROUND: Neonatal abstinence syndrome (NAS) is usually treated with opiate
derivatives and supported with nonpharmacological treatment. METHODS: This prospective …

Beyond the Finnegan scoring system: Novel assessment and diagnostic techniques for the opioid-exposed infant

DM Schiff, MR Grossman - Seminars in Fetal and Neonatal Medicine, 2019 - Elsevier
Infants with in-utero opioid exposure are most commonly assessed using the Finnegan
Neonatal Abstinence Scoring System (FNASS) or a modified version of that tool …

Autonomic nervous system functioning assessed during the still-face paradigm: A meta-analysis and systematic review of methods, approach and findings

K Jones-Mason, A Alkon, M Coccia, NR Bush - Developmental review, 2018 - Elsevier
Animal and human research suggests that the development of the autonomic nervous
system (ANS) is particularly sensitive to early parenting experiences. The Still-Face …

A quality improvement initiative to increase scoring consistency and accuracy of the Finnegan tool: challenges in obtaining reliable assessments of drug withdrawal in …

W Timpson, C Killoran, L Maranda… - Advances in Neonatal …, 2018 - journals.lww.com
Background: Current practice for diagnosing neonatal abstinence syndrome and guiding
pharmacological management of neonatal drug withdrawal is dependent on nursing …

Neonatal abstinence syndrome: review of epidemiology, care models, and current understanding of outcomes

KDL MacMillan - Clinics in perinatology, 2019 - perinatology.theclinics.com
Background Neonatal abstinence syndrome (NAS) includes an array of symptoms impacting
opioid-exposed newborns (OEN) owing to postnatal withdrawal from in utero substance …

Naltrexone in the treatment of opioid‐dependent pregnant women: the case for a considered and measured approach to research

HE Jones, MS Chisolm, LM Jansson, M Terplan - Addiction, 2013 - Wiley Online Library
The present paper considers naltrexone to treat opioid dependence during pregnancy. The
public health problem of opioid dependence and its treatment during pregnancy is reviewed …

Treating tobacco use disorder in pregnant women in medication-assisted treatment for an opioid use disorder: a systematic review

SC Akerman, MF Brunette, AI Green… - Journal of Substance …, 2015 - Elsevier
Smoking is associated with adverse effects on pregnancy and fetal development, yet 88–
95% of pregnant women in medication-assisted treatment for an opioid use disorder smoke …

Sex impact on biomarkers, pharmacokinetics and pharmacodynamics

F Franconi, I Campesi - Current medicinal chemistry, 2017 - ingentaconnect.com
Sex is one of several factors influencing pharmacological responses, but research on its
effects on pharmacokinetics and pharmacodynamics, although emerging remarkably …

Pharmacologic management of the opioid neonatal abstinence syndrome

WK Kraft, JN van den Anker - Pediatric Clinics, 2012 - pediatric.theclinics.com
Neonatal withdrawal symptoms have been noted following prenatal exposure to several
drugs. Examples include opioids, 1, 2 benzodiazepines, 3, 4 mood-stabilizing medications …